News

Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO₂, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings

• Replaces time-consuming manual spot checking with continuous, near real-time active patient monitoring
• Web-based system displays multiple patient physiological data continuously, with visual alarms and alert notifications for streamlined patient care
• Developed to support scalable population health management

Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.

LifeSignals receives CE Mark Approval for LifeSignals LX1550E Multiparameter Remote Monitoring Platform. Enables healthtech partners to deliver continuous remote patient vital signs monitoring within hospital and home settings.

LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance

World’s first single-use two channel ECG and heart rate biosensor provides 72- hour patient monitoring with remote data access in ambulatory, hospital and home settings

Continuous patient monitoring with remote data access in ambulatory, hospital and home settings enables faster clinical decision making

LifeSignals accelerates introduction of single-use wireless medical biosensor patches for COVID-19 mass population remote monitoring

LifeSignals receives HSA clearance for Tripatch™ ECG Remote Monitoring Biosensor Platform (LX1250) in Singapore

LifeSignals Inc., a global leader in the field of wireless biosensor technology through the LifeSignals Processor silicon platform, announced its merger with the connected health assets of Renew Health Limited (Renew), based in Ireland and Singapore.

LifeSignals, a pioneer in advanced biomonitoring, and ImagineMed, a provider of advanced telemedicine and remote health monitoring, announced today a partnership to bring clinical-grade, wireless monitoring to patients, enabling them to have the dual comfort of more freedom and more precise, real-time monitoring of their health metrics.

FDA Approval Paves Way for Next Generation of Remote Patient Diagnostics